✦ LIBER ✦

374 The Beneficial Effect of Beta-Blockers in Patients With Cirrhosis, Portal Hypertension, and Ascites

✍ Scribed by Mazhar, Khurram; Elliott, Alan C.; Rockey, Don C.

Book ID: 122191799
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 436 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)63514-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of beta-blockers on survival for

Effects of beta-blockers on survival for patients with cirrhosis and refractory ascites

✍ Gin-Ho Lo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.

Deleterious effects of beta-blockers on

Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites

✍ Mevlut Kurt 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 2 views

We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6

Deleterious effects of beta-blockers on

Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites

✍ Thomas Sersté; Christian Melot; Claire Francoz; François Durand; Pierre-Emmanuel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB 👁 2 views

Beta-blockers may have a negative impact on survival in patients with cirrhosis and refractory ascites. The aim of this study was to evaluate the effect of the administration of beta-blockers on long-term survival in patients with cirrhosis and refractory ascites. We performed a single-center, obser

Is this really the end of beta-blockers

Is this really the end of beta-blockers in patients with cirrhosis and refractory ascites?

✍ Thierry Thevenot; Jean-Paul Cervoni; Elisabeth Monnet; Frances Sheppard; Vincent 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB 👁 2 views

We read with interest the study by Sola `et al., 1 who found that 39 patients (67%) had a very alarming decrease in their serum sodium levels ! 5 mEq/L during terlipressin treatment for acute variceal bleeding (AVB). We, however, feel that some of their observations may require a closer look by the

Treatment of portal hypertensia by beta-

Treatment of portal hypertensia by beta-blockers and ACE-inhibitors in patients sick of cirrhosis and arterial hypertension

✍ OLGA MIHEEVA; LEONID LAZEBNIK 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Beneficial hemodynamic effects of ketans

Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: Possible role of serotonergic mechanisms in portal hypertension

✍ Antoine Hadengue; Samuel S. Lee; Richard Moreau; Alain Braillon; DR. Didier Lebr 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 2 views

We studied the acute effects of ketanserin, a serotonin Sz antagonist, on systemic and splanchnic hemodynamics in 11 patients with cirrhosis. Mean arterial pressure decreased moderately but significantly after ketanserin. This effect was maximal at 6 min and correlated to the severity of cirrhosis.